Researchers from Osaka Metropolitan University have identified a gene that, when activated by metabolic stress, damages ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

VX-880 stem cell therapy led to 92% reduction in insulin use, with 10 out of 12 patients eliminating injections entirely in a ...

In 2024, the smart insulin pens market generated roughly USD 4,253.3 million in revenues. The smart insulin pens market represents a significant advancement in diabetes management ... is the focus on ...

The writing panel, composed of 16 diabetes specialist physicians and allied health professionals from 13 countries, was led by David C. Klonoff, MD, medical director of the Dorothy L. and James E ...

It works extremely well for type 2 diabetes, a non-autoimmune disorder in which the body makes poor use of insulin. And one effect of semaglutide, as we all know now, has been the box-office draw ...

In preclinical experiments, icovamenib enhanced beta cell function and responsiveness of human islets to GLP-1-based therapies. These effects were associated with an increase in the expression ...